The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Aba978731
It is news like that which should have been on the latest RNS, which makes you wonder whether the RNS was also written in such a way to 'encourage' PI to also sell - for what end, only those two will know.
Normally when there is bad news, which a slight delay isnt really bad news, there is something written to soften the blow.
Very well said Wilson63. The article in the times has been published twice in a week for a reason and the editor is been followed by Doc holiday. Align research short this stock with inside knowledge before PR & BRH started dumping but these guys have been met with strong resistance as pi have huge appetite for RMS share. At least in the last 10 trading day, RMS share price has refuse to go below 2p despite all the negatives from vaccine to warrants to director selling which is why they are left in a state of confusion and resort to dirty game. If anyone fall for their dirty game, I will say no more. I am holding as things sort itself out.
Something else to think about; "Elsewhere in its operations, P2F has now completed the initial trial of its proprietary zinc nanotechnology, with positive results, at a citrus farm in the UK. P2F will commence trials in the USA shortly and if success is replicated in the USA trials, it expects to launch this product in early 2021, for farmers to apply during the 2021 growing season. The product is part of the company's nSitu™ range of nano-agritech materials, designed to support commercial farmers around the world - in this case by helping to protect the USA's annual 8 million tons of citrus fruit crops, with an estimated value of such crops of over $3.3 billion."
They short. They stated they had one open on tsla not long after.
Also tweet like a teenager going through a breakup, very strange.
Interesting company say they take shares in companies they believe in rather than payment. Stated last week they don't short as that would be illegal in their position but seem hell bent on telling retail investors to "keep selling"
Just my observations.
Out walking the dog over the fields this morning I could smell manure.